Also trades as: 0HI3.L (LSE) · $vol 0M
ARWR Smart Money
Arrowhead Pharmaceuticals, Inc.
1W: +0.2%
1M: -9.8%
3M: -31.5%
YTD: -12.9%
1Y: +55.3%
3Y: +132.0%
5Y: -12.0%
$59.03
+0.05 (+0.08%)
Weekly Expected Move ±4.7%
$53
$55
$58
$61
$63
Credit Risk of going bust: higher than 52% of companies Debt: 9.4% of company value Bonds: $79.9M held by 47 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.78 (down 99%), Arrowhead Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $864.1M against a stock market value of $8.34B.
Distance to default 4.96 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $452.0M (short-term plus half of long-term), stock volatility 60.3%; Altman Z'' 1.13. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.78 (down 99%), Arrowhead Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $864.1M against a stock market value of $8.34B.
Distance to default 4.96 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $452.0M (short-term plus half of long-term), stock volatility 60.3%; Altman Z'' 1.13. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026564
Institutions Holding
+61 vs prior
116.4%
Ownership
+26.59%
127
New
153
Increased
215
Reduced
57
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | PERRY MICHAEL S | director | S-Sale | 11,600 | $87.30 | $1.0M | Filing |
| 2026-08-18 | OLUKOTUN ADEOYE Y | director | S-Sale | 2,000 | $86.96 | $174K | Filing |
| 2026-06-15 | Cohen Matthew Gregory | director | A-Grant/Award | 11,882 | $— | $0 | Filing |
| 2026-05-12 | Lu Hongbo | director | S-Sale | 2,970 | $76.88 | $228K | Filing |
| 2026-04-23 | Hamilton James C | officer: chief medical officer | S-Sale | 10,000 | $75.00 | $750K | Filing |
| 2026-04-22 | Apel Daniel Joseph | officer: chief financial officer | S-Sale | 8,730 | $71.92 | $628K | Filing |
| 2026-04-22 | Apel Daniel Joseph | officer: chief financial officer | S-Sale | 1,157 | $70.45 | $82K | Filing |
| 2026-04-22 | Apel Daniel Joseph | officer: chief financial officer | S-Sale | 3,208 | $70.11 | $225K | Filing |
| 2026-01-06 | O'Brien Patrick | officer: coo | G-Gift | 540 | $— | $0 | Filing |
| 2026-01-06 | O'Brien Patrick | officer: coo | G-Gift | 440 | $— | $0 | Filing |
| 2026-01-06 | O'Brien Patrick | officer: coo | A-Grant/Award | 75,000 | $— | $0 | Filing |
| 2026-01-06 | Hamilton James C | officer: chief medical officer | A-Grant/Award | 75,000 | $— | $0 | Filing |
| 2026-01-06 | Apel Daniel Joseph | officer: chief financial officer | A-Grant/Award | 75,000 | $— | $0 | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 14,792 | $63.01 | $932K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 12,711 | $63.95 | $813K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 309 | $68.00 | $21K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 13,451 | $62.96 | $847K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 6,090 | $62.28 | $379K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 4,625 | $61.24 | $283K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 46 | $68.00 | $3K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 2,336 | $64.04 | $150K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 5,873 | $62.91 | $369K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 900 | $62.25 | $56K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 6,164 | $62.23 | $384K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 4,368 | $61.20 | $267K | Filing |
🏛️ Congressional Trades
1 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2023-01-31 | Daniel Goldman | House | Sell | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14,830,553 | $1.2B | -3,330,966 | 2026-06-30 | Filing |
| Avoro Capital Advisors LLC | 11,355,555 | $926M | +655,556 | 2026-06-30 | Filing |
| FMR LLC | 8,039,804 | $655M | +773,152 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,351,355 | $518M | -794,781 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,110,953 | $498M | +78,537 | 2026-06-30 | Filing |
| STATE STREET CORP | 5,694,640 | $464M | -801,490 | 2026-06-30 | Filing |
| NORGES BANK | 3,896,536 | $318M | +3,896,536 | 2026-06-30 | Filing |
| Invesco Ltd. | 3,883,976 | $317M | +603,329 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,530,612 | $299M | -748,216 | 2026-06-30 | Filing |
| FRED ALGER MANAGEMENT, LLC | 3,301,919 | $269M | -40,574 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 1,992,783 | $162M | — | 2026-06-30 | Filing |
| Siren, L.L.C. | 1,715,476 | $140M | +100,000 | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 1,575,000 | $128M | -700,000 | 2026-06-30 | Filing |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,389,055 | $113M | -184,242 | 2026-06-30 | Filing |
| FIRST TRUST ADVISORS LP | 1,352,918 | $110M | +1,203,770 | 2026-06-30 | Filing |
| Driehaus Capital Management LLC | 1,350,556 | $110M | +160,221 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 1,221,596 | $100M | +1,221,596 | 2026-06-30 | Filing |
| NORTHERN TRUST CORP | 1,192,868 | $97M | -462,969 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 1,181,608 | $96M | +573,077 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,150,007 | $94M | -589,916 | 2026-06-30 | Filing |